Aim: Abatacept In Inadequate Responders To Methotrexate Trademark Details

Aim: Abatacept in Inadequate Responders to Methotrexate was registered on Tuesday, January 20, 2009 and is currently owned by Bristol-Myers Squibb Company under the registration number 3565840 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, August 21, 2015, according to the United State Patent & Trademark Office
Word Mark Aim: Abatacept in Inadequate Responders to Methotrexate
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 78416531
Registration Number 3565840
Status Date Friday, August 21, 2015
Filing Date Friday, August 21, 2015
Registration Date Tuesday, January 20, 2009
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Disclaimer with Predetermined Text "Abatacept in Inadequate Responders to Methotrexate"
Goods & Services Clinical trials relating to pharmaceutical preparations for human use

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, August 21, 2015
First Use Anywhere Tuesday, June 20, 2006
First Use In Commerce Tuesday, June 20, 2006
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.